# Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Apellis Pharmaceuticals (APLS) sees social dominance surge 236% amid buyout rumors and clinical trial news, despite a Goldman Sachs downgrade. The stock is experiencing volatility as investors weigh conflicting signals.

### About Apellis Pharmaceuticals, Inc. Common Stock
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is a publicly traded stock in the healthcare sector.  
Apellis Pharmaceuticals, Inc. Common Stock uses the ticker $APLS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) social dominance is up 236% from the previous week.
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) posts created is up 86.67% from the previous week.

### Price: $21.70
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$apls/time-series/close.tsv)  
The stock price is under downward pressure due to a Goldman Sachs downgrade, which is outweighing a Wells Fargo upgrade and positive clinical trial results. Social media discussions about potential buyout offers are also contributing to the current volatility.  

24-Hour: -1.59%
7-Day: -7.62%
30-Day: 8.83%

1-Year High: $30.10 on 2025-10-28  
1-Year Low: $16.40 on 2025-05-15  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$apls/time-series/alt_rank.tsv)  
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is currently AltRank #1,401 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] [----]  
[--] Month: [-----] +349  
[--] Months: [-----] +941  
[--] Year: [-----] +643  
1-Year High: [-----] on 2026-02-13  
1-Year Low: [--] on 2025-03-15  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$apls/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-10-15  
1-Year Low: [--] on 2026-01-13  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$apls/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [------] -27%  
[--] Month: [-------] +1.80%  
[--] Months: [-------] -60%  
[--] Year: [---------] -53%  
1-Year High: [-------] on 2025-02-28  
1-Year Low: [---] on 2026-01-01  

Engagements by network (24h):
Reddit: [--]
X: [---]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$apls/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -31%  
[--] Month: [---] +18%  
[--] Months: [-----] -23%  
[--] Year: [-----] +13%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-12-14  

Mentions by network (24h):
Reddit: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$apls/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Apellis Pharmaceuticals, Inc. Common Stock (APLS) in the last [--] hours which is up 10% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -26%  
[--] Month: [---] +2.90%  
[--] Months: [-----] -29%  
[--] Year: [-----] +55%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-12-27  

The most influential creators that mention Apellis Pharmaceuticals, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@WolfOfPathogens](/creator/twitter/WolfOfPathogens) | [--]    | [--]         | [--]     | [---]         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@avinash_redekar](/creator/twitter/avinash_redekar) | [--]    | [------]    | [--]     | [--]          |
| [@LucyTrader98](/creator/twitter/LucyTrader98)       | [--]    | [---]       | [--]     | [--]          |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [--]          |
| [@KhannaVik86978](/creator/twitter/KhannaVik86978)   | [--]    | [--]         | [--]     | [--]          |
| [@jones_henr60023](/creator/twitter/jones_henr60023) | [--]    | [--]         | [--]     | [--]          |
| [@linhnguyen64143](/creator/twitter/linhnguyen64143) | [--]    | [--]        | [--]     | [--]           |
| [@marketsday](/creator/twitter/marketsday)           | [--]    | [------]    | [--]     | [--]           |

[View More](/list/creators/$apls/100)
  
  
### Sentiment: 71%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$apls/time-series/sentiment.tsv)  
Current Value: 71%  
Daily Average: 68%  
[--] Week: 100% no change  
[--] Month: 67% +15%  
[--] Months: 67% -22%  
[--] Year: 67% -15%  
1-Year High: 100% on 2025-04-13  
1-Year Low: 7% on 2025-09-09  

Most Supportive Themes:
- Positive Clinical Trial Results: (5%) Positive clinical trial results are a factor influencing the stock's performance.
- Potential Buyout Offers: (10%) Social media discussions about potential buyout offers are contributing to the current volatility.
  
Most Critical Themes:
- Goldman Sachs Downgrade: (15%) A recent downgrade by Goldman Sachs is exerting downward pressure on the stock price.
  
  
  
### Social Dominance: 0.00338%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$apls/time-series/social_dominance.tsv)  
Current Value: 0.00338%  
Daily Average: 0.013%  
[--] Week: 0.00336% +0.00236%  
[--] Month: 0.0039% -0.0059%  
[--] Months: 0.0039% -0.012%  
[--] Year: 0.0039% -0.025%  
1-Year High: 0.045% on 2025-06-29  
1-Year Low: 0.0019% on 2025-12-27  
  
  
### Market Dominance: 0.00311%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$apls/time-series/market_dominance.tsv)  
Current Value: 0.00311%  
Daily Average: 0%  
1-Year High: 0.00623% on 2025-03-12  
1-Year Low: 0.00283% on 2025-05-15  
  
  
### Market Cap: $2,745,597,231
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$apls/time-series/market_cap.tsv)  
Current Value: $2,745,597,231  
Daily Average: $2,816,757,986  
[--] Week: $2,745,597,231 -7.60%  
[--] Month: $2,745,597,231 +5.70%  
[--] Months: $2,745,597,231 -21%  
[--] Year: $2,745,597,231 -19%  
1-Year High: $3,802,082,801 on 2025-10-28  
1-Year Low: $2,056,161,774 on 2025-05-15  

### Top Apellis Pharmaceuticals, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$NWGL 🚀technical rebound: From 52wk low now $1.34 AH. Volume confirms strength $PLTR $META $PTON $MU $XOM $PYPL $LRE $IONQ $APLS $GME $AI $BB $CHPT $AAPL $ROKU $DJT $PFE $AMC $BRO $PATH $SOS $ALT $NVAX $TSLA $AMD $NVDA $TLRY $AMZN $NU $NUVA $MEGL $HKD $DXF $JZ $YJ $LGHL $QH"  
[X Link](https://x.com/Rocket_Labs22/status/2022500346916974825) [@Rocket_Labs22](/creator/x/Rocket_Labs22) 2026-02-14T02:37Z [---] followers, [---] engagements


"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona Lasofoxifene Fulvestrant ($1.2B annual) 87% Instit huge time arbtitrage oppor"  
[X Link](https://x.com/WolfOfPathogens/status/2022327290168782905) [@WolfOfPathogens](/creator/x/WolfOfPathogens) 2026-02-13T15:09Z [--] followers, [---] engagements


"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona lona 87% instit ownership/ Perceptive Tang capital $6.35m insider buy at $6.00 New phase [--] oncology asset"  
[X Link](https://x.com/WolfOfPathogens/status/2022028325682548910) [@WolfOfPathogens](/creator/x/WolfOfPathogens) 2026-02-12T19:21Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing